STOCK TITAN

Anvi Global OKs 1-for-20 reverse stock split

ANVI plans a 1-for-20 reverse stock split to help cure an OTCQB bid-price deficiency, pending SEC Schedule 14C clearance and FINRA approval.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ANVI GLOBAL HOLDINGS, INC. (ANVI) obtained majority stockholder written consent on September 4, 2026 to amend its Articles of Incorporation and implement a 1-for-20 reverse stock split of its issued and outstanding common stock. The approving holder owns 72,000,000 shares, or 60.03% of the 119,950,000 voting shares outstanding.

The reverse split is intended to address an OTCQB deficiency after ANVI’s bid price stayed below $0.01 for 30 consecutive days, triggering an initial cure deadline of October 5, 2026. The split will only become effective after SEC Schedule 14C clearance and FINRA approval, and at least 20 days following mailing of the definitive information statement.

Positive

  • None.

Negative

  • OTCQB bid-price deficiency and downgrade risk: ANVI’s minimum closing bid stayed below $0.01 for 30 consecutive days, leading to an OTCQB deficiency notice with an initial cure deadline of October 5, 2026 and the risk of a downgrade to the OTC Pink Open Market if compliance is not restored.

Filing Explained

The reverse split is approved but not effective; the filing also reports a delayed asset contribution and a pending 60-day cure-extension request.

The filing adds that the company pivoted to the approved reverse split after an intended exploration-mining-asset contribution was delayed; the split is not yet market-effective.

If completed, the 1-for-20 reverse split would reduce the number of shares and proportionally raise the per-share price, while the split itself would not change company value.

The company reports submitting a request for a 60-day listing cure-period extension after the asset transaction was delayed.

As of May 31, 2026, the latest supplied quarter reported $390 of cash and $14,369 of operating cash use.

At that quarter's operating cash-use rate, the cash balance equals 2.5 days of the last reported quarterly operating cash use.

The implementation path remains SEC Schedule 14C clearance, FINRA approval, and at least 20 calendar days after the definitive information statement is mailed and distributed; the extension request is a separate listing-status matter.

Sources and calculations
  • Available liquidity against the last reported quarterly operating outflow, in days at that rate $390 / ($14,369 / 92) = 2.5 days
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Majority holder shares 72,000,000 shares Shares of ANVI common stock whose holder approved the reverse split as of September 4, 2026
Total voting shares outstanding 119,950,000 shares Total issued and outstanding voting capital stock when consent was given
Majority ownership percentage 60.03% Portion of total voting shares held by the consenting stockholder
Reverse stock split ratio 1-for-20 Ratio for the structural reverse stock split of issued and outstanding common stock
OTCQB minimum bid threshold $0.01 Minimum closing bid price under OTCQB Continued Eligibility Criteria Section 2.1(A)
Consecutive days below threshold 30 days Period ANVI’s minimum closing bid stayed below $0.01, triggering deficiency notice
Initial cure deadline October 5, 2026 Deadline in the OTCQB deficiency notice for ANVI to regain compliance
Mailing wait period 20 calendar days Minimum time after mailing the Definitive Schedule 14C before the reverse split can become effective
Reverse Stock Split market
"to effectuate a structural reverse stock split of the Company’s issued"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Schedule 14C Information Statement regulatory
"file and distribute a Schedule 14C Information Statement to its"
OTCQB Venture Market market
"Our Common Stock is quoted on the OTCQB Venture Market under"
The OTCQB Venture Market is a tier of the over‑the‑counter (OTC) trading platform that groups early‑stage, smaller companies that do not meet the stricter requirements of higher OTC tiers. It gives investors a way to buy and sell shares in these higher‑risk, less mature firms with generally lower reporting and transparency standards; think of it as a marketplace’s “starter lane” where potential is available but uncertainty and volatility are higher, so investors should expect greater risk and do extra homework.
Continued Eligibility Criteria regulatory
"thereby failing to satisfy the Continued Eligibility Criteria under OTCQB"
FINRA Corporate Actions Gateway regulatory
"submitting an update notification to the FINRA Corporate Actions Gateway"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What corporate action did ANVI (ANVI) approve on September 4, 2026?

ANVI obtained written consent from the holder of 72,000,000 shares (about 60.03% of voting stock) to amend its Articles and implement a 1-for-20 reverse stock split of its issued and outstanding common stock, subject to SEC Schedule 14C clearance and FINRA approval.

Why is ANVI (ANVI) pursuing a 1-for-20 reverse stock split?

ANVI disclosed that its common stock’s minimum closing bid stayed below $0.01 for 30 consecutive days, triggering an OTCQB deficiency notice. Management pivoted to a structural 1-for-20 reverse stock split to address the bid-price requirement and avoid a potential downgrade to the OTC Pink Open Market.

When can ANVI’s reverse stock split become effective?

The reverse stock split cannot become effective until at least 20 calendar days after a Definitive Schedule 14C Information Statement has been completely mailed to stockholders and remains strictly subject to SEC Schedule 14C clearance and FINRA approval.

What ownership stake approved ANVI’s reverse stock split?

A single holder of 72,000,000 shares of ANVI common stock, representing approximately 60.03% of the 119,950,000 issued and outstanding voting shares, executed a Written Consent approving the 1-for-20 reverse stock split without a physical stockholder meeting.

What OTCQB compliance issue does ANVI (ANVI) face and by when?

On June 6, 2026 ANVI received an OTCQB deficiency notice because its minimum closing bid was below $0.01 for 30 consecutive days, breaching OTCQB Rules Section 2.1(A). The notice set an initial compliance cure deadline of October 5, 2026; ANVI is requesting a 60-day extension.

How will ANVI notify stockholders about the reverse stock split?

ANVI will file and distribute a Schedule 14C Information Statement to non-consenting stockholders of record. The reverse split cannot become mechanically effective until at least 20 calendar days after the Definitive Schedule 14C has been fully mailed and distributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001570132 0001570132 2026-09-04 2026-09-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 4, 2026

ANVI GLOBAL HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   333-188648   33-1226144
(State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)
         

 

1135 Kildaire Farm Road, Suite 319-4    
Cary, NC   27511
(Address of principal executive offices)     (Zip Code)

 

  (919) 439-4448  
  (Registrant’s telephone number, including area code)  

 

Not Applicable 

(Former name, or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A    N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On September 4, 2026, the holder of 72,000,000 shares of Common Stock, representing approximately 60.03% of the 119,950,000 total issued and outstanding shares of voting capital stock of ANVI Global Holdings, Inc. (the “Company”), executed a Written Consent in lieu of a special meeting of stockholders (the “Stockholder Consent”).

 

The Stockholder Consent approved an amendment to the Company’s Amended and Restated Articles of Incorporation to effectuate a structural reverse stock split of the Company’s issued and outstanding Common Stock at a ratio of one-for-twenty (1-for-20) (the “Reverse Stock Split”). The Board of Directors of the Company previously approved, adopted, and declared advisable the Reverse Stock Split and recommended it to the stockholders on August 29, 2026.

 

Pursuant to Section 78.320 of the Nevada Revised Statutes and the Company’s governing documents, any action required or permitted to be taken at a meeting of stockholders may be taken without a meeting, without prior notice, and without a vote, if a consent or consents in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting. Accordingly, the written approval by the majority stockholder is sufficient to adopt the Reverse Stock Split under Nevada law without a physical meeting or vote of the remaining stockholders.

 

In accordance with rules and regulations promulgated under the Securities Exchange Act of 1934, specifically SEC Rule 14c-2, the Company will file and distribute a Schedule 14C Information Statement to its non-consenting stockholders of record. The Reverse Stock Split cannot become mechanically effective in the marketplace until at least twenty (20) calendar days after a Definitive Information Statement on Schedule 14C has been completely mailed and distributed to our stockholders of record. The final implementation and market effective date of this transaction remain strictly subject to SEC Schedule 14C clearance and FINRA approval.

 

Item 8.01 Other Events.

 

Our Common Stock is quoted on the OTCQB Venture Market under the symbol “ANVI.” On June 6, 2026, the Company received a formal deficiency notice from OTC Markets Group Inc. stating that the Company’s minimum closing bid price fell below $0.01 for 30 consecutive calendar days, thereby failing to satisfy the Continued Eligibility Criteria under OTCQB Rules Section 2.1(A). The notice established an initial compliance cure deadline of October 5, 2026.

 

Following receipt of the notice, the Company evaluated a proposed corporate transaction to inject an exploration mining asset directly onto the Company’s balance sheet as a capital contribution. Management intended to completely finalize the mechanical asset transfer within the window; however, the definitive exploration and technical phase of the mine could not be completed within that anticipated timeframe. This delay was severely compounded by unexpected regional geopolitical tensions, which temporarily halted field operations and international technical clearings.

 

Recognizing that these compliance and operational hurdles had indefinitely delayed the asset transaction, management pivoted to a structural reverse stock split adjustment to definitively address the bid price requirement and avoid a listing downgrade to the OTC Pink Open Market. Concurrently with the filing of this Current Report, the Company is submitting an update notification to the FINRA Corporate Actions Gateway and transmitting a formal request to OTC Markets Group Compliance for a 60-day listing cure period extension. The reverse stock split transaction is strictly subject to SEC Schedule 14C clearance and FINRA approval.

 

Item 9.01. Financial Statements and Exhibits.

       
(d) Exhibits    
 

 

Exhibit

Number

  Description
  10.1   Board of Directors Written Resolutions dated August 29, 2026.
  10.2   Stockholder Written Consent in Lieu of a Special Meeting dated September 4, 2026.
  104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 
       

ANVI GLOBAL HOLDINGS, INC.

 

       
September 11, 2026       By:   /s/ Rama Mohan R. Busa
                Name: Rama Mohan R. Busa
                Title: Chief Executive Officer & Sole Director

 

 

 

 

Filing Exhibits & Attachments

5 documents

Keep reading